The funding will enable James to start a new research group that will span the National Heart & Lung Institute, Royal Brompton Hospital's cardiovascular biomedical research unit (BRU) and Medical Research Council's (MRC) Clinical Sciences Centre. This group will be looking into the genetic causes of unexplained cardiomyopathy, the clinical significance and mechanisms of action of Titin gene variants, and the clinical interpretation of genomes in patient care.
James says: “I am delighted to have been awarded this fellowship. We hope the research programme will help lead to a better understanding of the impact of genetic variation on the heart – improving diagnosis and providing opportunities to discover more targeted treatments for patients living with dilated cardiomyopathy and other inherited heart diseases in the future.”
Back to BRU news